Methods of treating fibrosis
AssigneeNogra Pharma Limited
InventorsSergio Baroni, Salvatore Bellinvia, Francesca Viti
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed in part to methods of treating fibrosis, e.g., hepatic fibrosis and/or intestinal fibrosis, comprising administering to a patient in need thereof an effective amount of a disclosed compound.
Claims9
A method of treating alpha 1-antitrypsin deficiency in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound, wherein the compound is 2-methoxy-3-(4′-aminophenyl) propionic acid, represented by the formula:
- or a pharmaceutically acceptable salt or a stereoisomer thereof.
A method of treating alpha 1-antitrypsin deficiency in a subject in need thereof, comprising administering to the subject a pharmaceutical preparation comprising a therapeutically effective amount of 2-methoxy-3-(4′-aminophenyl) propionic acid (compound 34), or a pharmaceutically acceptable salt or a stereoisomer thereof, and one or more pharmaceutically acceptable carriers.
Dependencies are inferred from the claim text.